The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Weekly paclitaxel (P), carboplatin (CP) plus pembrolizumab (PMB) as first-line treatment of recurrent or metastatic (R/M) or locally very advanced (LVA) head and neck squamous cell carcinoma (HNSCC): A retrospective study in 39 patients (pts).
 
Christian Borel
Honoraria - Merck KGaA; MSD
Consulting or Advisory Role - Merck KGaA; MSD
Travel, Accommodations, Expenses - Merck KGaA; MSD
 
Hélène Carinato
No Relationships to Disclose
 
Carole Pflumio
Honoraria - Lilly; Seagen
Consulting or Advisory Role - Novartis
Travel, Accommodations, Expenses - Pfizer
 
Elodie Poprawa
No Relationships to Disclose
 
Youssef Brahimi
No Relationships to Disclose
 
Marine Oriel
No Relationships to Disclose
 
Clara Vacheret
No Relationships to Disclose
 
Delphine Ravily
No Relationships to Disclose
 
Pierre Coliat
Travel, Accommodations, Expenses - Gilead Sciences; Merck KGaA
 
Thierry Petit
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo; Lilly; Pfizer; Seagan
Travel, Accommodations, Expenses - Lilly; MSD; Pfizer
 
Mickael Burgy
Consulting or Advisory Role - Lilly
Travel, Accommodations, Expenses - Eisai